Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Flexion Therapeutics, Inc. (FLXN)

« Back to company index

FLXN Chatter Timeline

Stock Ticker for FLXN

Most Active Tweeters for FLXN

UserTweets
@Tickeron 11
@stockmktgenius 7
@jodietheai 7
@newsfilterio 3
@Gambiste1 3

Recent Tweets for FLXN

Tickeron @Tickeron
$FLXN's Aroon indicator drops into Downtrend on January 8, 2020. View odds for this and other indicators:… https://t.co/ooVkUjB95G
January 18th 2020, 9:01pm
Tickeron @Tickeron
$FLXN's Aroon indicator drops into Downtrend on January 8, 2020. View odds for this and other indicators:… https://t.co/STapkkZJtO
January 17th 2020, 10:01pm
Tickeron @Tickeron
$FLXN's Aroon indicator drops into Downtrend on January 8, 2020. View odds for this and other indicators:… https://t.co/TfdyeKoGpr
January 16th 2020, 9:01pm
bio_report @bio_report
$FLXN This fall getting ridiculous following guiding next year revenue in-line with analyst projections.
January 16th 2020, 2:01pm
SwingTradeBot @SwingTradeBot
Outside Day today: $FLXN ... https://t.co/Ya1wmaeD73
January 16th 2020, 1:01pm
stockmktgenius @stockmktgenius
$FLXN Flexion Therapeutics, Inc #LeaderPullBack Close: 18.24 Liq: $11M https://t.co/a3LT62D8Uj
January 15th 2020, 10:01pm
stockmktgenius @stockmktgenius
$FLXN Flexion Therapeutics, Inc #LeaderPullBack Close: 18.47 Liq: $17M https://t.co/a3LT62D8Uj
January 14th 2020, 10:01pm
dailypoliticaln @dailypoliticaln
Flexion Therapeutics Inc $FLXN Given Consensus Recommendation of “Buy” by Analysts https://t.co/g0VUhH2q7D
January 14th 2020, 9:01pm
fda_tracker @fda_tracker
$FLXN Phase 3 trial w/est Jan completion date NCT03529942: https://t.co/zmQ3Gkh2cf Trial Tracker: https://t.co/aR7q5orVrP
January 14th 2020, 9:01am
Tickeron @Tickeron
$FLXN's Aroon indicator drops into Downtrend on January 8, 2020. View odds for this and other indicators:… https://t.co/otDNZRoqsS
January 13th 2020, 9:01pm
stockmktgenius @stockmktgenius
$FLXN Flexion Therapeutics, Inc #LeaderPullBack Close: 18.45 Liq: $15M https://t.co/a3LT62D8Uj
January 13th 2020, 5:01pm
SwingTradeBot @SwingTradeBot
Fell Below 50 DMA today: $FLXN ... https://t.co/j2lcQOTpfA
January 13th 2020, 2:01pm
gcassidy718 @gcassidy718
$FLXN I’ll probably buy on the dip. Still need to do more research. -10.51 % https://t.co/N7BKQfHT0R
January 13th 2020, 10:01am
otcdynamics @otcdynamics
$FLXN Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2020 and Provides Corporate Update https://t.co/mRIVC654SO
January 13th 2020, 9:01am
Tickeron @Tickeron
$FLXN's Aroon indicator drops into Downtrend on January 8, 2020. View odds for this and other indicators:… https://t.co/eHTI1i6NLb
January 12th 2020, 9:01pm
TheMarketsDaily @TheMarketsDaily
Flexion Therapeutics Inc $FLXN Receives $25.88 Consensus Target Price from Brokerages https://t.co/fE8Wme5jqs
January 12th 2020, 12:01pm
stocknewstimes @stocknewstimes
Flexion Therapeutics Inc $FLXN Receives $25.88 Consensus Price Target from Brokerages https://t.co/HoUrAvSVmv
January 12th 2020, 12:01pm
newsfilterio @newsfilterio
Flexion Therapeutics Inc Receives $25.88 Consensus Price Target from Brokerages $FLXN https://t.co/R2YpHvYJXv
January 12th 2020, 12:01pm
WatchlistN @WatchlistN
Flexion Therapeutics $FLXN Trading Down 10.5% https://t.co/jjT5sStq2b
January 12th 2020, 11:01am
dispatchtribune @dispatchtribune
Flexion Therapeutics $FLXN Shares Down 10.5% https://t.co/Q19mu0duSF
January 12th 2020, 11:01am
Tickeron @Tickeron
$FLXN's Aroon indicator drops into Downtrend on January 8, 2020. View odds for this and other indicators:… https://t.co/uPk0LYEgIT
January 12th 2020, 1:01am
BlueBioNow @BlueBioNow
$FLXN might be worth taking a position when this bottoms -10.51 % change recently https://t.co/HjeJMAJFlT
January 11th 2020, 11:01pm
Tickeron @Tickeron
$FLXN in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators:… https://t.co/H5Uz1qoyhU
January 10th 2020, 10:01pm
BlueBioNow @BlueBioNow
$FLXN What happened??? why the bounce?? -5.25 % change recently https://t.co/HjeJMAJFlT
January 10th 2020, 9:01pm
Gambiste1 @Gambiste1
RT @CloisterRes: Why am I not short more $FLXN?
January 10th 2020, 5:01pm
CloisterRes @CloisterRes
Why am I not short more $FLXN?
January 10th 2020, 4:01pm
WatchlistN @WatchlistN
Flexion Therapeutics $FLXN Lowered to Hold at BidaskClub https://t.co/iDu2iWNmet
January 10th 2020, 3:01pm
mahangtia @mahangtia
Long more $FLXN $19.45
January 10th 2020, 3:01pm
bio_report @bio_report
$FLXN guiding in line next year which is expected at 50-60% year over year growth and stock down?
January 10th 2020, 10:01am
OpenOutcrier @OpenOutcrier
$FLXN (-3.0% pre) Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter and Full-Year 2019 Revenue a… https://t.co/ncTfMerB6Y
January 10th 2020, 8:01am
ThisLincolnian @ThisLincolnian
Analysts Set Flexion Therapeutics Inc $FLXN Price Target at $25.88 https://t.co/M8prRrynSx
January 10th 2020, 6:01am
EnterpriseLeade @EnterpriseLeade
Analysts Set Flexion Therapeutics Inc $FLXN PT at $25.88 https://t.co/5CLedoZ7N1
January 10th 2020, 6:01am
newsfilterio @newsfilterio
Flexion Therapeutics Downgraded by BidaskClub $FLXN https://t.co/LShEnfQqbJ
January 10th 2020, 12:01am
Tickeron @Tickeron
$FLXN's Aroon indicator drops into Downtrend on January 8, 2020. View odds for this and other indicators:… https://t.co/QNhvg1eMcX
January 9th 2020, 10:01pm
Gambiste1 @Gambiste1
RT @LavaCreekVOS: $FLXN provides updated revenue guidance...continues to make progress with Zilretta (extended relief injection treatment f…
January 9th 2020, 8:01pm
LavaCreekVOS @LavaCreekVOS
$FLXN provides updated revenue guidance...continues to make progress with Zilretta (extended relief injection treat… https://t.co/Cuh4eUSOtw
January 9th 2020, 7:01pm
Briefingcom @Briefingcom
$FLXN: Flexion Therapeutics guides Q4 revs slightly below consensus; guides for 2020 ZILRETTA product revenue https://t.co/6fm7gXS92G
January 9th 2020, 6:01pm
stockmktgenius @stockmktgenius
$FLXN Flexion Therapeutics, Inc Top stock up 133% from low. Close: 21.13 VolvsAvg: 0.61 Liq: $22M https://t.co/a3LT62D8Uj
January 9th 2020, 5:01pm
WeekHerald @WeekHerald
Zacks: Brokerages Expect Flexion Therapeutics Inc $FLXN Will Announce Earnings of -$1.01 Per Share https://t.co/qi5TvVRik4
January 9th 2020, 5:01pm
OlympiaReport @OlympiaReport
Flexion Therapeutics Inc $FLXN Expected to Post Quarterly Sales of $23.05 Million https://t.co/ZP2KYnLUkU
January 9th 2020, 5:01pm
dakotafinancial @dakotafinancial
-$1.01 Earnings Per Share Expected for Flexion Therapeutics Inc $FLXN This Quarter https://t.co/oUTGFQiESk
January 9th 2020, 5:01pm
dispatchtribune @dispatchtribune
$23.05 Million in Sales Expected for Flexion Therapeutics Inc $FLXN This Quarter https://t.co/D3uohJk2iJ
January 9th 2020, 5:01pm
newsfilterio @newsfilterio
Flexion sees Zilretta sales as high as $135M this year $FLXN https://t.co/Ss6uyL9zL8
January 9th 2020, 4:01pm
StckPro @StckPro
$FLXN NEW ARTICLE : Flexion sees Zilretta sales as high as $135M this year https://t.co/aVKJ9pjGDD Get all the late… https://t.co/XkDTK8LvNJ
January 9th 2020, 4:01pm
MarketCurrents @MarketCurrents
$FLXN - Flexion sees Zilretta sales as high as $135M this year https://t.co/TiEBgru0wL
January 9th 2020, 4:01pm
otcdynamics @otcdynamics
$FLXN Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter and Full-Year 2019 Revenue and Initial https://t.co/wxseM3Z6O8
January 9th 2020, 4:01pm
TheMarketsDaily @TheMarketsDaily
Flexion Therapeutics $FLXN Stock Rating Lowered by BidaskClub https://t.co/3yPtjKNsF4
January 9th 2020, 2:01pm
stocknewstimes @stocknewstimes
Flexion Therapeutics $FLXN Downgraded by BidaskClub https://t.co/DkHcZVe7qA
January 9th 2020, 2:01pm
bbnsnews @bbnsnews
Flexion Therapeutics $FLXN – Research Analysts’ Recent Ratings Updates https://t.co/rcP8aNyHHc
January 9th 2020, 4:01am
AmericanBanking @AmericanBanking
Flexion Therapeutics $FLXN – Research Analysts’ Recent Ratings Updates https://t.co/JA5f4Ph7NA #stocks
January 9th 2020, 4:01am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.